Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:CGC NASDAQ:CRON On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.37-1.4%$1.29$0.77▼$5.80$333.39M0.7722.56 million shs14.76 million shsCRONCronos Group$2.53-1.9%$2.31$1.60▼$2.77$987.86M1.133.01 million shs1.30 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth0.00%-6.16%-8.05%-7.43%-70.91%CRONCronos Group0.00%+1.20%+0.40%+31.09%+16.06%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCGCCanopy Growth$1.37-1.4%$1.29$0.77▼$5.80$333.39M0.7722.56 million shs14.76 million shsCRONCronos Group$2.53-1.9%$2.31$1.60▼$2.77$987.86M1.133.01 million shs1.30 million shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCGCCanopy Growth0.00%-6.16%-8.05%-7.43%-70.91%CRONCronos Group0.00%+1.20%+0.40%+31.09%+16.06%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCGCCanopy Growth 1.33SellN/AN/ACRONCronos Group 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest CGC and CRON Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails8/12/2025CGCCanopy GrowthZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold(Data available from 9/14/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCGCCanopy Growth$274.92M1.20N/AN/A$1.90 per share0.72CRONCronos Group$130.28M7.44$0.00 per share5,544.57$2.90 per share0.87Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCGCCanopy Growth-$429.86M-$3.03N/AN/AN/A-155.76%-89.93%-44.24%11/14/2025 (Estimated)CRONCronos Group$41.08M$0.0550.6084.33N/A14.19%-3.78%-3.62%11/11/2025 (Estimated)Latest CGC and CRON EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/8/2025Q1 2026CGCCanopy Growth-$0.15-$0.14+$0.01-$0.16$64.98 million$52.98 million8/7/2025Q2 2025CRONCronos Group-$0.02-$0.10-$0.08-$0.10$45.73 million$33.46 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCGCCanopy GrowthN/AN/AN/AN/AN/ACRONCronos GroupN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCGCCanopy Growth0.593.072.12CRONCronos GroupN/A24.6523.53Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCGCCanopy Growth3.33%CRONCronos Group8.71%Insider OwnershipCompanyInsider OwnershipCGCCanopy Growth0.16%CRONCronos Group7.30%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableCGCCanopy Growth3,150239.85 million239.47 millionOptionableCRONCronos Group450382.89 million354.94 millionOptionableCGC and CRON HeadlinesRecent News About These Companies3 Marijuana Stocks For Better Gains This MonthSeptember 12 at 10:18 AM | marijuanastocks.comMOne Cronos: The New Dawn Feature Expertly Merges Story and GameplaySeptember 11 at 3:47 AM | msn.comCronos Pump: Will Trump’s Social Plan Drive CRO Price?September 10, 2025 | finance.yahoo.comPresident Trump’s Truth Social To Allow Subscribers To Convert Loyalty Points Into Cronos (CRO) TokensSeptember 9, 2025 | dailyhodl.comDTruth Social and Truth+ allow users to convert gems into Cronos token, dropping plans for proprietary tokenSeptember 9, 2025 | cryptobriefing.comCNuveen LLC Buys Shares of 189,422 Cronos Group Inc. $CRONSeptember 8, 2025 | marketbeat.comCannabis Stock CRON Trades Near 52-Week High: How to PlaySeptember 5, 2025 | zacks.com3 Top Canadian Marijuana Stock Choices For A Possible Breakout In 2025September 3, 2025 | marijuanastocks.comMCronos Group (NASDAQ:CRON) Upgraded to "Hold" at Wall Street ZenSeptember 1, 2025 | marketbeat.comCronos Soars Past $0.3 as Best Wallet Presale Raises $15M: Best Utility Tokens to Buy?August 29, 2025 | cryptopolitan.comCCronos Group (NASDAQ:CRON) Sees Unusually-High Trading Volume - Here's What HappenedAugust 27, 2025 | marketbeat.comCronos Price Prediction: CRO Soars 39% As Trump Media, Crypto.com Plan $6.4 Billion CRO Treasury FirmAugust 27, 2025 | insidebitcoins.comICryptocurrencies Price Prediction: Ethereum, Bitcoin & Cronos – European Wrap 27 AugustAugust 27, 2025 | fxstreet.comCronos Soars 39% On $6.4B Trump Media And Crypto.com CRO Treasury Plan, ETH Jumps 4% As Standard Chartered Says It’s `Cheap:’ Market WrapAugust 27, 2025 | insidebitcoins.comIBitcoin, Ethereum, XRP, Cronos Gain. 2 Ways Trump Is Boosting Cryptos.August 27, 2025 | barrons.comCrypto Gainers Today: Cronos, Numeraire and Hyperliquid rally as bullish news fuels momentumAugust 27, 2025 | fxstreet.comTrump Media Partners With Crypto.com on Crypto Treasury CompanyAugust 26, 2025 | msn.comCrypto.com's native token rallies 25% after new merger dealAugust 26, 2025 | msn.comUS cannabis stocks rally as Trump backs reschedulingAugust 26, 2025 | proactiveinvestors.com3 Top Canadian Marijuana Stocks Impacted By The Cannabis IndustryAugust 22, 2025 | marijuanastocks.comMCronos Group (NASDAQ:CRON) Stock Price Up 8.2% - What's Next?August 20, 2025 | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCGC and CRON Company DescriptionsCanopy Growth NASDAQ:CGC$1.37 -0.02 (-1.44%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$1.37 +0.00 (+0.07%) As of 09/12/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in the United States, Canada, Germany, and internationally. It operates through Canada Cannabis, International Markets Cannabis, and Storz & Bickel segments. The company offers dried flower, pre-rolled joints, oils, softgel capsules, infused beverages, edibles comprising gummies, and topical formats, as well as vaporizer devices. It sells its products under the Tweed, 7ACRES, DOJA, Deep Space, HiWay, Maitri, Twd., Vert, Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Martha Stewart, and Wana brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.Cronos Group NASDAQ:CRON$2.53 -0.05 (-1.94%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$2.52 0.00 (-0.20%) As of 09/12/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Cronos Group Inc. operates as a cannabinoid company that engages in the cultivation, production and marketing of cannabis products in Canada, Israel, and Germany. It offers dried flower, pre-rolls, oils, vaporizers, edibles, and cannabis tinctures under the Spinach, Lord Jones, and PEACE NATURALS brands. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 09/08 - 09/12 Meta's $600B U.S. Investment: Bearish or Bullish for Shares? Post Onum Deal: Is CrowdStrike Ready to Rebound After 16% Drop? Chewy’s September Pullback: Is It Your Time to Buy? It’s Time to Buy the Dip in Kroger Stock Price Is Coupang the Next MercadoLibre? A Playbook for Global Dominance Vanguard’s VUG ETF: The Ultimate Growth ETF for Your Portfolio Tesla's U.S. Market Is At An 8-Year Low... How Bad Could It Get? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.